References
- Berenson JR, Yellin O, Cartmell AD, . A phase II study of pegylated liposomal doxorubicin (PLD), bortezomib, dexamethasone and lenalidomide (DVD-R) for patients with relapsed/refractory (R/R) multiple myeloma (MM). Blood 2010;116(Suppl. 1):Abstract 3044.
- Varettoni M, Corso A, Pica G, . Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients. Ann Oncol 2010;21:325–330.
- Gozzetti A, Cerase A, Lotti F, . Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: a retrospective survey of 50 patients. Cancer 2012;118:1574–1184.
- Chamberlain MC, Glantz M. Myelomatous meningitis. Cancer 2008;112:1562–1567.
- Nieuwenhuizen L, Biesma DH. Central nervous system myelomatosis: review of the literature. Eur J Haematol 2008;80:1–9.
- Petersen SL, Wagner A, Gimsing P. Cerebral and meningeal multiple myeloma after autologous stem cell transplantation. A case report and review of the literature. Am J Hematol 1999;62:228–233.
- Fassas AB, Muwalla F, Berryman T, . Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations. Br J Haematol 2002;117:103–108.
- Chang H, Sloan S, Li D, . Multiple myeloma involving central nervous system: high frequency of chromosome 17p13.1 (p53) deletions. Br J Haematol 2004;127:280–284.
- Chang H, Bartlett ES, Patterson B, . The absence of CD56 on malignant plasma cells in the cerebrospinal fluid is the hallmark of multiple myeloma involving central nervous system. Br J Haematol 2005;129:539–541.
- Patriarca F, Prosdocimo S, Tomadini V, . Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation. Haematologica 2005;90:278–279.
- Muscal JA, Sun Y, Nuchtern JG, . Plasma and cerebrospinal fluid pharmacokinetics of thalidomide and lenalidomide in nonhuman primates. Cancer Chemother Pharmacol 2012;69:943–947.
- Vicari P, Ribas C, Sampaio M, . Can thalidomide be effective to treat plasma cell leptomeningeal infiltration?Eur J Haematol 2003;70:198–199.
- Lacy MQ, Rajkumar SV. Pomalidomide: a new IMiD with remarkable activity in both multiple myeloma and myelofibrosis. Am J Hematol 2009;85:95–96.
- Moghadddam M, Katz J, Tang Y. Brain microdialysis of pomalidomide in rats. Presented at the 17th North American Regional ISSX Meeting. October 2011. Atlanta, GA. Abstract #P91.
- Short KD, Rajkumar SV, Larson D, . Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma. Leukemia 2011;25:906–908.